165 related articles for article (PubMed ID: 29038460)
1. A novel immunohistochemical score to predict early mortality in acute myeloid leukemia patients based on indoleamine 2,3 dioxygenase expression.
Mangaonkar A; Mondal AK; Fulzule S; Pundkar C; Park EJ; Jillella A; Kota V; Xu H; Savage NM; Shi H; Munn D; Kolhe R
Sci Rep; 2017 Oct; 7(1):12892. PubMed ID: 29038460
[TBL] [Abstract][Full Text] [Related]
2. Expression of indoleamine 2,3-dioxygenase in leukemic cells indicates an unfavorable prognosis in acute myeloid leukemia patients with intermediate-risk cytogenetics.
Fukuno K; Hara T; Tsurumi H; Shibata Y; Mabuchi R; Nakamura N; Kitagawa J; Shimizu M; Ito H; Saito K; Moriwaki H
Leuk Lymphoma; 2015 May; 56(5):1398-405. PubMed ID: 25248875
[TBL] [Abstract][Full Text] [Related]
3. Investigating the Role of Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia: A Systematic Review.
Wells G; Kennedy PT; Dahal LN
Front Immunol; 2021; 12():651687. PubMed ID: 33777052
[No Abstract] [Full Text] [Related]
4. Prognostic value of the combination of serum l-kynurenine level and indoleamine 2,3-dioxygenase mRNA expression in acute myeloid leukemia.
Hara T; Matsumoto T; Shibata Y; Nakamura N; Nakamura H; Ninomiya S; Kitagawa J; Nannya Y; Shimizu M; Ito H; Saito K; Tsurumi H
Leuk Lymphoma; 2016 Sep; 57(9):2208-11. PubMed ID: 26762931
[No Abstract] [Full Text] [Related]
5. Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia.
Folgiero V; Goffredo BM; Filippini P; Masetti R; Bonanno G; Caruso R; Bertaina V; Mastronuzzi A; Gaspari S; Zecca M; Torelli GF; Testi AM; Pession A; Locatelli F; Rutella S
Oncotarget; 2014 Apr; 5(8):2052-64. PubMed ID: 24903009
[TBL] [Abstract][Full Text] [Related]
6. Indoleamine 2,3-dioxygenase activity of acute myeloid leukemia cells can be measured from patients' sera by HPLC and is inducible by IFN-gamma.
Corm S; Berthon C; Imbenotte M; Biggio V; Lhermitte M; Dupont C; Briche I; Quesnel B
Leuk Res; 2009 Mar; 33(3):490-4. PubMed ID: 18639339
[TBL] [Abstract][Full Text] [Related]
7. Expression of indoleamine 2,3-dioxygenase in acute myeloid leukemia and the effect of its inhibition on cultured leukemia blast cells.
El Kholy NM; Sallam MM; Ahmed MB; Sallam RM; Asfour IA; Hammouda JA; Habib HZ; Abu-Zahra F
Med Oncol; 2011 Mar; 28(1):270-8. PubMed ID: 20300979
[TBL] [Abstract][Full Text] [Related]
8. Role of indoleamine 2,3-dioxygenase in acute myeloid leukemia.
Sobash PT; Kolhe R; Karim NA; Guddati AK; Jillella A; Kota V
Future Oncol; 2020 Dec; 16(36):3085-3094. PubMed ID: 32976029
[TBL] [Abstract][Full Text] [Related]
9. Indoleamine 2,3-dioxygenase and regulatory T cells in acute myeloid leukemia.
Mansour I; Zayed RA; Said F; Latif LA
Hematology; 2016 Sep; 21(8):447-53. PubMed ID: 27077762
[TBL] [Abstract][Full Text] [Related]
10. [Indoleamine 2, 3-dioxygenase activity in acute myeloid leukemia cells contributing to tumor immune escape].
Tang XQ; Zhao ZG; Wang HX; Li QB; Lü J; Zou P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):539-42. PubMed ID: 16800938
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.
Brandacher G; Perathoner A; Ladurner R; Schneeberger S; Obrist P; Winkler C; Werner ER; Werner-Felmayer G; Weiss HG; Göbel G; Margreiter R; Königsrainer A; Fuchs D; Amberger A
Clin Cancer Res; 2006 Feb; 12(4):1144-51. PubMed ID: 16489067
[TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic impact of indoleamine 2,3-dioxygenase in oral squamous cell carcinomas.
Laimer K; Troester B; Kloss F; Schafer G; Obrist P; Perathoner A; Laimer J; Brandacher G; Rasse M; Margreiter R; Amberger A
Oral Oncol; 2011 May; 47(5):352-7. PubMed ID: 21440489
[TBL] [Abstract][Full Text] [Related]
13. [EFFECTS OF INDOLEAMINE 2, 3-DIOXYGENASE GENE MODIFIED BONE MARROW MESENCHYMAL STEM CELLS IN RAT COMPOSITE TISSUE ALLOGRAFT REJECTION].
Han F; Wang Y; Wang Y; Jia Y; Yang L; Jia W; Fang X; Bai X; Hu D
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Jun; 28(6):745-51. PubMed ID: 26455230
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Indoleamine 2,3-dioxygenase (IDO) Expression on Stage III Gastric Cancer.
Nishi M; Yoshikawa K; Higashijima J; Tokunaga T; Kashihara H; Takasu C; Ishikawa D; Wada Y; Shimada M
Anticancer Res; 2018 Jun; 38(6):3387-3392. PubMed ID: 29848687
[TBL] [Abstract][Full Text] [Related]
15. High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome.
Chamuleau ME; van de Loosdrecht AA; Hess CJ; Janssen JJ; Zevenbergen A; Delwel R; Valk PJ; Löwenberg B; Ossenkoppele GJ
Haematologica; 2008 Dec; 93(12):1894-8. PubMed ID: 19050070
[TBL] [Abstract][Full Text] [Related]
16. Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma.
Riesenberg R; Weiler C; Spring O; Eder M; Buchner A; Popp T; Castro M; Kammerer R; Takikawa O; Hatz RA; Stief CG; Hofstetter A; Zimmermann W
Clin Cancer Res; 2007 Dec; 13(23):6993-7002. PubMed ID: 18056175
[TBL] [Abstract][Full Text] [Related]
17. Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer.
Zhang T; Tan XL; Xu Y; Wang ZZ; Xiao CH; Liu R
Chin Med J (Engl); 2017 Mar; 130(6):710-716. PubMed ID: 28303855
[TBL] [Abstract][Full Text] [Related]
18. High serum concentration of L-kynurenine predicts unfavorable outcomes in patients with acute myeloid leukemia.
Mabuchi R; Hara T; Matsumoto T; Shibata Y; Nakamura N; Nakamura H; Kitagawa J; Kanemura N; Goto N; Shimizu M; Ito H; Yamamoto Y; Saito K; Moriwaki H; Tsurumi H
Leuk Lymphoma; 2016; 57(1):92-8. PubMed ID: 25907424
[TBL] [Abstract][Full Text] [Related]
19. [Expression and Activity Regulation of Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia Cells].
Liao J; Li YP; Huang JM; Li G
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1633-1638. PubMed ID: 28024468
[TBL] [Abstract][Full Text] [Related]
20. High Indoleamine 2,3-Dioxygenase Is Correlated With Microvessel Density and Worse Prognosis in Breast Cancer.
Wei L; Zhu S; Li M; Li F; Wei F; Liu J; Ren X
Front Immunol; 2018; 9():724. PubMed ID: 29719533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
